CD244 represents a new therapeutic target in head and neck squamous cell carcinoma.
J Immunother Cancer. 2020 Mar;8(1):e000245. doi: 10.1136/jitc-2019-000245.
J Immunother Cancer. 2020.
PMID: 32217758
Free PMC article.